| Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications LA García Rodríguez, KJ Lin, S Hernández-Díaz, S Johansson Circulation 123 (10), 1108-1115, 2011 | 244 | 2011 |
| The effect of estrogen vs. combined estrogen‐progestogen therapy on the risk of colorectal cancer KJ Lin, WY Cheung, JYC Lai, EL Giovannucci International journal of cancer 130 (2), 419-430, 2012 | 198 | 2012 |
| Comparison of video laryngoscopes with direct laryngoscopy for tracheal intubation: a meta-analysis of randomised trials YC Su, CC Chen, YK Lee, JY Lee, KJ Lin European Journal of Anaesthesiology| EJA 28 (11), 788-795, 2011 | 188 | 2011 |
| Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy KJ Lin, S Hernández–Díaz, LAG Rodríguez Gastroenterology 141 (1), 71-79, 2011 | 136 | 2011 |
| Emulation of randomized clinical trials with nonrandomized database analyses: results of 32 clinical trials SV Wang, S Schneeweiss, JM Franklin, RJ Desai, W Feldman, EM Garry, ... Jama 329 (16), 1376-1385, 2023 | 116 | 2023 |
| Safety of macrolides during pregnancy KJ Lin, AA Mitchell, WP Yau, C Louik, S Hernández-Díaz American journal of obstetrics and gynecology 208 (3), 221. e1-221. e8, 2013 | 116 | 2013 |
| Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates? KJ Lin, LA García Rodríguez, S Hernández‐Díaz Pharmacoepidemiology and drug safety 20 (7), 718-728, 2011 | 108 | 2011 |
| Use of decongestants during pregnancy and the risk of birth defects WP Yau, AA Mitchell, KJ Lin, MM Werler, S Hernández-Díaz American journal of epidemiology 178 (2), 198-208, 2013 | 103 | 2013 |
| Effectiveness and safety of apixaban compared with rivaroxaban for patients with atrial fibrillation in routine practice: a cohort study M Fralick, M Colacci, S Schneeweiss, KF Huybrechts, KJ Lin, JJ Gagne Annals of internal medicine 172 (7), 463-473, 2020 | 90 | 2020 |
| Maternal exposure to amoxicillin and the risk of oral clefts KJ Lin, AA Mitchell, WP Yau, C Louik, S Hernández-Díaz Epidemiology 23 (5), 699-705, 2012 | 89 | 2012 |
| Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs KJ Lin, S Schneeweiss Clinical Pharmacology & Therapeutics 100 (2), 147-159, 2016 | 69 | 2016 |
| Impact of metabolic syndrome on the risk of atrial fibrillation recurrence after catheter ablation: systematic review and meta-analysis KJ Lin, SI Cho, N Tiwari, M Bergman, JR Kizer, EC Palma, CC Taub Journal of Interventional Cardiac Electrophysiology 39, 211-223, 2014 | 57 | 2014 |
| Identifying patients with high data completeness to improve validity of comparative effectiveness research in electronic health records data KJ Lin, DE Singer, RJ Glynn, SN Murphy, J Lii, S Schneeweiss Clinical Pharmacology & Therapeutics 103 (5), 899-905, 2018 | 49 | 2018 |
| Out-of-system care and recording of patient characteristics critical for comparative effectiveness research KJ Lin, RJ Glynn, DE Singer, SN Murphy, J Lii, S Schneeweiss Epidemiology 29 (3), 356-363, 2018 | 48 | 2018 |
| Development and preliminary validation of a Medicare claims–based model to predict left ventricular ejection fraction class in patients with heart failure RJ Desai, KJ Lin, E Patorno, J Barberio, M Lee, R Levin, T Evers, ... Circulation: Cardiovascular Quality and Outcomes 11 (12), e004700, 2018 | 40 | 2018 |
| Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention: a population-based, nested case–control study KJ Lin, R De Caterina, LAG Rodríguez Circulation: Cardiovascular Quality and Outcomes 7 (1), 70-77, 2014 | 38 | 2014 |
| Trends in use of oral anticoagulants in older adults with newly diagnosed atrial fibrillation, 2010-2020 D Ko, KJ Lin, LG Bessette, SB Lee, AJ Walkey, S Cheng, E Kim, RJ Glynn, ... JAMA Network Open 5 (11), e2242964-e2242964, 2022 | 37 | 2022 |
| Real‐world evidence for assessing pharmaceutical treatments in the context of COVID‐19 JM Franklin, KJ Lin, NM Gatto, JA Rassen, RJ Glynn, S Schneeweiss Clinical Pharmacology & Therapeutics 109 (4), 816-828, 2021 | 33 | 2021 |
| Pharmacotherapy for hospitalized patients with COVID-19: treatment patterns by disease severity KJ Lin, S Schneeweiss, H Tesfaye, E D’Andrea, J Liu, J Lii, SN Murphy, ... Drugs 80, 1961-1972, 2020 | 29 | 2020 |
| Validation of obesity‐related diagnosis codes in claims data K Suissa, S Schneeweiss, KJ Lin, G Brill, SC Kim, E Patorno Diabetes, Obesity and Metabolism 23 (12), 2623-2631, 2021 | 28 | 2021 |
